This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Lipid-lowering Effect of Plant Stanol Drink

This study has been completed.
Information provided by (Responsible Party):
Raisio Group Identifier:
First received: October 25, 2012
Last updated: October 26, 2012
Last verified: October 2012
To determine the effect of investigational products on serum LDL cholesterol.

Condition Intervention
Hypercholesterolemia Dietary Supplement: Drink that contains plant stanols Dietary Supplement: Placebo drink

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Plant Stanol Drink on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol Concentrations

Resource links provided by NLM:

Further study details as provided by Raisio Group:

Primary Outcome Measures:
  • Change in serum LDL cholesterol [ Time Frame: Four weeks ]

Enrollment: 56
Study Start Date: January 2011
Study Completion Date: June 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Drink that contains plant stanols
Dietary supplement: Plant stanol
Dietary Supplement: Drink that contains plant stanols
Placebo Comparator: Placebo drink
Dietary supplement: Placebo
Dietary Supplement: Placebo drink


Ages Eligible for Study:   25 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • healthy mildly to moderate hypercholesterolemic (serum total cholesterol 5.2-8.5 mmol/l) adults
  • signed written informed consent

Exclusion Criteria:

  • participation in a clinical study within 30 days prior to screening visit and throughout the study
  • severe obesity
  • consumption of lipid/cholesterol lowering medication 1 month prior to the screening visit and throughout the study
  • consumption of plant stanol or plant sterol containing food products such as Benecol or Becel pro active 1 month prior to visit 2
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01716390

Good Food Practice
Uppsala, Sweden
Sponsors and Collaborators
Raisio Group
Principal Investigator: Johan Olsson, PhD Good Food Practice, Uppsala, Sweden
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Raisio Group Identifier: NCT01716390     History of Changes
Other Study ID Numbers: CL2010_029
Study First Received: October 25, 2012
Last Updated: October 26, 2012

Additional relevant MeSH terms:
Lipid Metabolism Disorders
Metabolic Diseases processed this record on August 21, 2017